1. Home
  2. TPST vs DTST Comparison

TPST vs DTST Comparison

Compare TPST & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • DTST
  • Stock Information
  • Founded
  • TPST 2011
  • DTST 2001
  • Country
  • TPST United States
  • DTST United States
  • Employees
  • TPST N/A
  • DTST N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • DTST EDP Services
  • Sector
  • TPST Health Care
  • DTST Technology
  • Exchange
  • TPST Nasdaq
  • DTST Nasdaq
  • Market Cap
  • TPST 33.0M
  • DTST 28.2M
  • IPO Year
  • TPST N/A
  • DTST N/A
  • Fundamental
  • Price
  • TPST $7.44
  • DTST $3.52
  • Analyst Decision
  • TPST Hold
  • DTST
  • Analyst Count
  • TPST 3
  • DTST 0
  • Target Price
  • TPST $30.00
  • DTST N/A
  • AVG Volume (30 Days)
  • TPST 234.4K
  • DTST 33.5K
  • Earning Date
  • TPST 08-07-2025
  • DTST 08-13-2025
  • Dividend Yield
  • TPST N/A
  • DTST N/A
  • EPS Growth
  • TPST N/A
  • DTST N/A
  • EPS
  • TPST N/A
  • DTST 0.02
  • Revenue
  • TPST N/A
  • DTST $25,219,312.00
  • Revenue This Year
  • TPST N/A
  • DTST $12.57
  • Revenue Next Year
  • TPST N/A
  • DTST $9.29
  • P/E Ratio
  • TPST N/A
  • DTST $151.10
  • Revenue Growth
  • TPST N/A
  • DTST N/A
  • 52 Week Low
  • TPST $5.35
  • DTST $2.93
  • 52 Week High
  • TPST $30.03
  • DTST $6.82
  • Technical
  • Relative Strength Index (RSI)
  • TPST 56.13
  • DTST 48.25
  • Support Level
  • TPST $7.06
  • DTST $3.33
  • Resistance Level
  • TPST $7.18
  • DTST $3.65
  • Average True Range (ATR)
  • TPST 0.28
  • DTST 0.13
  • MACD
  • TPST 0.03
  • DTST 0.02
  • Stochastic Oscillator
  • TPST 93.18
  • DTST 67.50

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

Share on Social Networks: